omparing the genetic events between benign and malignant gastric polyps, several recurrent mutations in DNA methylation (*TET0*, V000I), the β-catenin pathway (*CTNNB0*, S00F) and RHO signaling pathway (*PLEKHG0*, R000C) were identified